MGX Total Aset Bisnis Metagenomi Inc.

Simbol resmi perusahaan Metagenomi Therapeutics (MGX)

International conflicts and sanctions hinder Metagenomi, Inc. (MGX) from accessing global genetic archives, slowing biomedical research. The absence of commercial products leaves the company dependent on external investments, with total assets amounting to 223.00. The market price reflected in this chart demonstrates the potential of this biotech firm, which is developing ultra-precise DNA modification tools based on unique microbial libraries for the therapy of complex pathologies.

Aset Agregat Perusahaan Metagenomi (MGX): kanggo periode 21.02.2024 - 31.10.2026
Produk mawa merek Metagenomi Inc.

Seeking to redefine gene editing precision standards through metagenomics, Metagenomi (MGX) requires significant resources to develop innovative CRISPR tools. An analysis of total assets, reverse-calculated via ROA and reaching a value of 223.00, allows for an assessment of the company's aggregate capital and liabilities, which for this class of venture securities serves as an indicator of financial stability and the scale of its technological potential.

Pesaing langsung

Total Aset Bisnis TEM|Aset Agregat Perusahaan Qiagen|Total Aset Bisnis IONS (Ionis Pharmaceuticals, Inc.)|Total Aset Perusahaan RGEN|Total Aset Perusahaan Avidity Corp (RNA)|Aset Agregat Perusahaan CRISPR Therapeutics AG CRSP|WGS - Gunggung Aset Perusahaan|Ultragenyx - Total Aset Perusahaan|Aset Perusahaan Beam Therapeutics Inc|SRPT (Sarepta Therapeutics Inc) - Gunggung Aset Perusahaan|TWST: Aset Agregat Bisnis|TXG (10x Genomics, Inc.) - Total Aset Perusahaan|Total Aset Perusahaan intelliatx.com|Total Aset Perusahaan STOK|BioLife Solutions Inc (BLFS) - Aset Neraca Perusahaan|Total Aset Perusahaan WVE (Wave Life Sciences Corp)|Maze Therapeutics Corp (MAZE) - Aset Perusahaan|SION - Aset Agregat Perusahaan|PRME (primemedicine.com) - Total Aset Bisnis|Taysha Gene Therapies, Inc. (TSHA) - Aset Agregat Perusahaan|Aset Perusahaan uniQure NV (QURE)|Aset Agregat Perusahaan MeiraGTx PLC|Gunggung Aset Perusahaan REGENXBIO Corp (RGNX)|Total Aset Perusahaan SLDB|Gunggung Aset Perusahaan ocugen.com|PacBio - Gunggung Aset Perusahaan|Nilai Agregat Aset BNTC|Design Pharma - Total Aset Perusahaan|Gunggung Aset Perusahaan Rocket Corp RCKT|4D Molecular Therapeutics (FDMT) - Aset Agregat Perusahaan|Total Aset Bisnis LXEO|KRRO (Korro Bio Inc.) - Total Aset Perusahaan|Gunggung Aset Perusahaan Editas Medicine Inc (EDIT)|Gunggung Aset Perusahaan SLN (Silence Therapeutics Inc.)|Gunggung Aset Perusahaan proqr.com|Aset Agregat Perusahaan Codexis CDXS|SGMO - Gunggung Aset Perusahaan|Nautilus Biotechnology Inc - Total Aset Perusahaan|Aset Neraca Perusahaan precisionbiosciences.com (DTIL)|GBIO (generationbio.com) - Gunggung Aset Perusahaan|Total Aset Bisnis BOLD|XCUR (Exicure Inc.) - Total Aset Perusahaan|Total Aset Bisnis IMNN (Celsion Corporation)|Aset Agregat Perusahaan Phio Pharmaceuticals (PHIO)|mustangbio.com - Total Aset Bisnis|Total Aset Perusahaan RNAZ (TransCode Therapeutics, Inc.)|Total Aset Perusahaan Bionano Genomics Inc. BNGO|APDN - Aset Agregat Perusahaan|bluebirdbio.com (BLUE) - Gunggung Aset Perusahaan|IPA: Total Aset Perusahaan|Aset Perusahaan Omega Therapeutics Inc (OMGA)|Gunggung Aset Perusahaan OMIC|RGLS (Regulus) - Aset Agregat Bisnis|Total Aset Perusahaan SYRS|Total Aset Perusahaan telesisbio.com (TBIO)|Total Aset Perusahaan TCON (TRACON Pharmaceuticals, Inc.)|Aset Neraca Perusahaan Unity Biotechnology Inc.